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StructureThe novel 43-residue, insect defensin-like peptide coprisin, isolated from the dung beetle, Copris tripartitus,
is a potent antibiotic with bacterial cell selectivity, exhibiting antimicrobial activities against Gram-positive
and Gram-negative bacteria without exerting hemolytic activity against human erythrocytes. Tests against
Staphylococcus aureus using ﬂuorescent dye leakage and depolarization measurements showed that
coprisin targets the bacterial cell membrane. To understand structure–activity relationships, we deter-
mined the three-dimensional structure of coprisin in aqueous solution by nuclearmagnetic resonance spec-
troscopy, which showed that coprisin has an amphipathic α-helical structure from Ala19 to Arg28, and
β-sheets from Gly31 to Gln35 and Val38 to Arg42. Coprisin has electropositive regions formed by Arg28,
Lys29, Lys30, and Arg42 and ITC results proved that coprisin and LPS have electrostatically driven interac-
tions. Using measurements of nitric oxide release and inﬂammatory cytokine production, we provide the
ﬁrst veriﬁcation of the anti-inﬂammatory activity and associated mechanism of an insect defensin, demon-
strating that the anti-inﬂammatory actions of the defensin-like peptide, coprisin, are initiated by suppress-
ing the binding of LPS to toll-like receptor 4, and subsequently inhibiting the phosphorylation of p38
mitogen-activated protein kinase and nuclear translocation of NF-kB. In conclusion, we have demonstrated
that an amphipathic helix and an electropositive surface in coprisin may play important roles in its effective
interaction with bacterial cell membranes and, ultimately, in its high antibacterial activity and potent
anti-inﬂammatory activity. In addition to elucidating the antimicrobial action of coprisin, this work may
provide insight into the mechanism of action of insect defense systems.
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Antimicrobial peptides (AMPs) have been found in a variety of or-
ganisms, including mammals, amphibians, and insects. These natural
antimicrobial peptides are known to play important roles in host
defense systems and innate immunity [1–3]. Recently, the rapid
emergence of antibiotic-resistant bacterial and fungal strains has
raised considerable interest in using natural antimicrobial peptides
as therapeutic agents [4,5]. Many of these peptides promptly destroy
assaulting pathogens through membrane permeabilization, although
this may not be their sole action prior to cell lysis. The antibiotic
action of most AMPs seems to involve depolarization and/or perme-
abilization of the bacterial cell membrane, although the precise mech-
anisms have not been fully characterized [1–6].
Defensins are evolutionarily conserved AMPs with a distinctive
β-sheet structure that is stabilized by three disulﬁde bonds. Most mam-
malian defensins have antimicrobial activity against bacteria and fungi
[7,8], and defensins are widely distributed at high concentrations in
mammalian phagocytes and epithelial cells. Mammalian defensins
include three defensin subfamilies, α-defensins, β-defensins and
θ-defensins, which differ in the length of segments between their six
cysteines and in the pairing of cysteines, which are connected by disul-
ﬁde bonds. Bothα-defensins andβ-defensins are composed of a charac-
teristic β-sheet with three disulﬁde bonds, whereas θ-defensins
generate a cyclic structure through splicing and cyclization of two of
the 9-amino-acid segments. In comparison, insect defensins consist of
anα-helix which is disulﬁde-linked to a β-sheet through cysteine link-
ages (1–4, 2–5, 3–6) that differ from those of vertebrate defensins [9].
Investigations of mammalian α-defensins, such as human, rabbit
and guinea pig, have revealed that these proteins induce degranulation
and histamine release in mast cells [10,11]. Neutrophil defensins medi-
ate inﬂammatory responses in tissue injury, mainly in the lung. High
concentrations of defensins are present in inﬂamed tissues, and cells ex-
posed to defensins generate pro-inﬂammatory signals [12]. Defensins
likely promote the recruitment of neutrophils to inﬂammatory sites,
given that neutrophil inﬁltration [13,14] is regulated by mast cells.
The anti-inﬂammatory activities of human defensins have been exten-
sively studied. Studies of various types of cytokines have demonstrated
that human neutrophil peptides-1, -2, and -3 (HNP1, -2, and -3;
α-defensins) and human β-defensins are associatedwith inﬂammatory
responses [15–18].
Recent studies of the innate immune response of insects have
revealed that AMPs have a crucial role in the host defense against
bacterial pathogens, rendering insects extremely resistant to bacterial
infections [19–21]. Among the insect-derived AMPs, defensin was
found to contribute greatly to the innate immunity of insects [22].
The ﬁrst insect defensin peptide was isolated by Homma et al. [23]
from the ﬂesh ﬂy, Sarcophaga peregrina. Since then, numerous
defensins have been isolated from various insects, and defensins
have been found to act against Gram-positive and Gram-negative
bacteria and fungi [24–26]. Peptides in the insect defensin family
commonly have molecular weights of 3–4 kDa and contain three
disulﬁde bridges. Amino acid alignments of the insect defensin
family indicate that the disulﬁde bridges are conserved in insect
defensin peptides. We recently isolated a novel 43-residue peptide
(VTCDVLSFEAKGIAVNHSACALHCIALRKKGGSCQNGVCVCRN) from lar-
vae of the dung beetle, Copris tripartitus [27]. This peptide, termed
coprisin, exhibits high sequence similarity to other insect defensins,
such as Anomala defensin A from Anomala cuprea [28].
Previously, we showed that coprisin induces apoptosis in C. albicans,
resulting in antifungal activity [29]. The anti-inﬂammatory activities of
insect defensins have been rarely reported to date, whereas those of
mammalian defensins are well known. Therefore, in this study, we
investigated the antimicrobial and anti-inﬂammatory activities of
coprisin and sought to elucidate its mechanism of action for the ﬁrst
time. We investigated its mode of action by testing its ability topermeate model phospholipid membranes. The anti-inﬂammatory
activity of coprisin was established by examining the inhibition of ni-
trite production and expression of mRNAs for inﬂammatory cytokines
in lipopolysaccharide (LPS)-stimulated RAW264.7 cells. We also inves-
tigated the innate defense response mechanisms engaged by coprisin.
Finally, we studied the tertiary structure of coprisin using nuclear mag-
netic resonance (NMR) spectroscopy and investigated the structural
features that play important roles in its antimicrobial activity and inter-
action with LPS.
2. Materials and methods
2.1. Peptide synthesis
Coprisin was synthesized by solid-phase synthesis using
ﬂuorenylmethoxycarbonyl (Fmoc) chemistry. The peptide was pu-
riﬁed by reverse-phase preparative high-performance liquid chro-
matography (HPLC) on a C18 column (20×250 mm; Shim-pack)
using an appropriate 0−90% water/acetonitrile gradient in the
presence of 0.05% triﬂuoroacetic acid. Analytical HPLC with an
octadecyl silica (ODS) column (4.6×250 mm; Shim-pack) revealed
that puriﬁed peptides were more than 98% homogeneous (data not
shown). The molecular mass of puriﬁed peptides was determined
by matrix-assisted laser-desorption ionization-time-of-ﬂight mass
spectrometry (MALDI-TOF MS) (Shimadzu, Kyoto, Japan) (theoretical
mass: 4468.1 Da, actualmass: 4467.7 Da). The concentration of coprisin
was quantiﬁed using a UV spectrometer.
2.2. Antibacterial activity
Escherichia coli (KCTC 1682), Pseudomonas aeruginosa (KCTC 1637),
Salmonella typhimurium (KCTC 1926), Bacillus subtilis (KCTC 3068),
Staphylococcus epidermidis (KCTC 1917), and Staphylococcus aureus
(KCTC 1621) were purchased from the Korean Collection for Type Cul-
tures (KCTC), Korea Research Institute of Bioscience & Biotechnology
(Taejon, Korea). The clinical isolates of methicillin-resistant S. aureus
(MRSA) (CCARM 3089, CCARM 3090, CCARM 3108, CCARM 3114, and
CCARM 3126), multidrug-resistant S. typhimurium (MDRST) (CCARM
8003, CCARM 8007, and CCARM 8009), and multidrug-resistant E. coli
(MDREC) (CCARM 1229 and CCARM 1238) were supplied from the
Culture Collection of Antibiotic-Resistant Microbe (CCARM) at Seoul
Women's University in Korea. Minimum inhibitory concentrations
(MICs) of coprisin against bacteria were determined using a broth
microdilution assay and compared with those of melittin as described
previously [30]. The lowest concentration of peptide that completely
inhibited growth was deﬁned as MIC. MIC values were calculated as
the average of triplicate measurements in 3 independent assays.
2.3. Hemolytic activity
The hemolytic activity of coprisin was tested against human red
blood cells (hRBCs) as described previously [30]. The release of hemo-
globin was monitored by measuring the absorbance at 405 nm. No
hemolysis (blank) and 100% hemolysis controls consisted of hRBCs
suspended in PBS and 0.1% Triton-X 100, respectively. Percent hemo-
lysis was calculated using the following equation:
Hemolysis %ð Þ ¼ ½ OD405 nmsample−OD405 nmzero lysisð Þ
= OD405 nm100% lysis−OD405 nmzerolysisð Þ  100:
2.4. Cytotoxicity against RAW264.7 and HaCaT cells
The mouse macrophage-derived RAW264.7 cell line and human
keratinocyte HaCaT cell line were purchased from the American
Type Culture Collection (ATCC, Manassas, VA). RAW264.7 cells were
273E. Lee et al. / Biochimica et Biophysica Acta 1828 (2013) 271–283cultured in Roswell Park Memorial Institute (RPMI)-1640 media
supplemented with 10% fetal bovine serum (FBS) and antibiotic
solution (100 units/ml penicillin and 100 μg/ml streptomycin).
HaCaT cells were cultured in Dulbecco's Modiﬁed Eagle Medium
(DMEM) supplemented with 10% FBS and antibiotic solution
(100 units/ml penicillin and 100 μg/ml streptomycin) at 37 °C in a
humidiﬁed 5% CO2 atmosphere. Cultures were passaged every 2–3 d
by brief trypsin treatment, and visualized with an inverted micro-
scope. The cytotoxicity of peptides against mammalian cells was deter-
mined using a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT) assay as reported previously [31], withminormodiﬁca-
tions. Brieﬂy, RAW264.7 cells were seeded on 96-well microplates at a
density of 1×104 cells/well in 100 μl of RPMI-1640 containing 10%
FBS and 1% antibiotics, and HaCaT cells were seeded on 96-well
microplates at a density of 1×104 cells/well in 100 μl of DMEM
containing 10% FBS and 1% antibiotics. Plates were incubated for 24 h
at 37 °C in 5% CO2. Serial 2-fold dilutions of peptide solutions (100 μl)
in RPMI-1640 or DMEM were added; wells containing cells without
peptides served as controls. After incubating plates for 1 d, 20 μl of
MTT solution (5 mg/ml)was added to eachwell, and the plateswere in-
cubated for an additional 4 h at 37 °C. Precipitated MTT formazan was
dissolved by adding 100 μl of dimethyl sulfoxide (DMSO). Absorbance
at 570 nm was measured using an enzyme-linked immunosorbent
assay (ELISA) reader (Molecular Devices, Sunnyvale, CA). Cell survival,
expressed as a percentage, was calculated as the ratio of A570 for cells
treated with peptide to that of cells without peptide treatment.2.5. Quantiﬁcation of NO production in LPS-stimulated RAW264.7 cells
Nitrite accumulation in culture media was used as an indicator of
NO production [32]. RAW264.7 cells were plated at a density of
1×105cells/well in 96-well culture plates and stimulated with LPS
(20 ng/ml) from E. coli O111:B4 (Sigma) in the presence or absence
of peptides for 24 h. Isolated supernatant fractions were mixed
with an equal volume of Griess reagent (1% sulfanilamide, 0.1%
naphthylethylenediamine dihydrochloride, 2% phosphoric acid) and
incubated at room temperature (RT) for 10 min. Nitrite production
was determined by measuring absorbance at 540 nm, and converting
values to nitrite concentrations using a standard curve generated
with NaNO2.2.6. Quantiﬁcation of inﬂammatory cytokine (mTNF-α and mMIP-2)
production by ELISA in LPS-stimulated RAW264.7 cells
Antibodies against mouse tumor necrosis factor α (mTNF-α)
and mouse macrophage inﬂammatory protein 2 (mMIP-2) were
immobilized on immunoplates by incubation with 0.2–0.8 μg/ml
solutions of antibody in PBS overnight at RT. Plates were washed
once with PBS/0.1% Tween-20 (PBST) and blocked by incubating with
200 μl of blocking solution (3% bovine serum albumin [BSA], 0.02%
NaN3 in PBS) overnight at RT. Then, supernatants from LPS-stimulated
RAW264.7 cells co-incubated with serially diluted peptide for 18 h
were added to the wells of pre-coated plates and incubated for 2 h at
RT. After washing plates 3 times with PBST, biotinylated-anti-mTNF-α
antibody (0.4 μg/ml) was diluted in 0.1% BSA and added, and plates
were incubated for 2 h. Plates were then washed 3 times with PBST,
and further incubated with streptavidin peroxidase (0.3 μg/ml) diluted
in PBS. After washing, SureBlue 3,3′,5,5′-tetramethylbenzidine (TMB)
peroxidase substrate (KPL, Inc., Gaithersburg, MD) was added. The en-
zyme reaction was allowed to proceed at RT for color development,
and was stopped by adding 100 μl of 1 M H2SO4. The absorbance at
450 nm was detected using a microplate reader. All values represent
the means±standard deviations of at least 3 independent experiments
[33].2.7. Reverse transcription-polymerase chain reaction
Mouse RAW264.7 cells were plated in 6-well plates (5×105 cells/
well) and cultured overnight. Cells were stimulated without (nega-
tive control) or with 20 ng/ml LPS in the presence or absence of pep-
tide in RPMI-1640 supplemented with 1% penicillin/streptomycin for
3 h. After stimulation, cells were detached from the wells by cold PBS
and washed once with PBS. Competitive reverse transcription-
polymerase chain reaction (RT-PCR) was performed as described pre-
viously [34]. Brieﬂy, total RNA was extracted using an RNeasy kit
(QIAGEN, Hilden, Germany), according to the manufacturer's instruc-
tions, and equal amounts of total RNA were reverse transcribed into
cDNA using oligo(dT)-15 primers. The indicated targets were ampliﬁed
from the resulting cDNA by PCR using the speciﬁc primers as described
previously [35]. mIL-1β primers were 5′-CTG TCC TGA TGA GAG CAT
CC-3′ (sense), 5′-TGT CCA TTG AGG TGG AGA GC-3′ (antisense);
mMIP-1 primers were 5′-ATG AAG CTC TGC GTG TCT GC-3′ (sense),
5′-TGA GGA GCA AGG ACG CTT CT-3′ (antisense); mMIP-2 primers
were 5′-ACA CTT CAG CCT AGC GCC AT-3′ (sense), 5′-CAG GTC AGT
TAG CCT TGC CT-3′ (antisense); mTNF-α primers were 5′-GTT CTG
TCC CTT TCA CTC ACT G-3′ (sense), 5′-GGT AGA GAA TGG ATG AAC
ACC-3′ (antisense); miNOS primers were 5′-CTG CAG CAC TTG GAT
CAG GAA CCT G-3′ (sense), 5′-GGG AGT AGC CTG TGT GCA CCT GGA
A-3′ (antisense); and GAPDH primers were 5′-ACC ACA GTC CAT GCC
ATC AC-3′ (sense), 5′-TCC ACC ACC CTG TTG CTG TA-3′ (antisense).
GAPDH was used as an internal standard. PCR was performed using
the following cycling conditions: 94 °C for 5 min, followed by 25 cycles
of 94 °C for 1 min, 55 °C for 1.5 min and 72 °C for 1 min, and a ﬁnal
extension step of 72 °C for 5 min. Ampliﬁed products were
electrophoresed on 1% agarose gels, and bands were visualized by UV
illumination of ethidium bromide-stained gels.
2.8. Western blotting
RAW264.7 cells were seeded in 6-well plates (3×106 cells/well) and
incubated in RPMI-1640 (Welgene, Daegu, Korea) supplemented with
10% FBS (Invitrogen, Grand Island, NY) and antibiotics (100 U/ml peni-
cillin, 100 μg/ml streptomycin; Invitrogen) at 37 °C under 5% CO2. Cul-
tured cellswere stimulatedwith 100 ng/ml LPS for 6 h, afterwhich cells
were incubated overnight with coprisin (20 μM). After incubation, cells
were washed twice with PBS and detached with ice-cold PBS. The col-
lected cells were centrifuged at 1000 rpm for 5 min at 4 °C. Cell pellets
were re-suspended in 100 μl of lysis buffer (1% Triton X-100, 1%
deoxycholate, 0.1% NaN3) and incubated for 30 min on ice. Lysed cells
were centrifuged at 12,000 rpm for 10 min at 4 °C, and the concentra-
tion of protein in the supernatant (cytoplasmic extract) was deter-
mined by performing the Bradford assay (Bio-Rad, Hemel Hempstead,
UK). Nuclear extracts were prepared from the remaining pellets using
NE-PER™ nuclear extraction reagent (Pierce, Rockford, IL). Equal
amounts of protein (25 μg) were separated by sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) on a 10% gel
and transferred to a polyvinylidene ﬂuoride (PVDF)microporousmem-
brane (Millipore, Billerica,MA). Themembranewas blockedby incubat-
ing with 5% skim milk in Tris-buffered saline with Tween 20 (TBST;
25 mM Tris, 3 mM KCl, 140 mM NaCl, 0.1% Tween 20) for 1 h at RT,
and then incubated with antibodies speciﬁc for toll-like receptor 4
(TLR4, 1:1000; Cell Signaling Technology, Beverly, MA), p38 mitogen-
activated protein kinase (phospho-p38 MARK, 1:1000; Cell Signaling
Technology), nuclear factor κ-light chain-enhancer of activated B cells
(NF-κB, 1:1000, Cell Signaling Technology) and β-actin (1:5000;
Sigma-Aldrich, St. Louis, MO). After washing with TBST buffer, the
membrane was incubated with horseradish peroxidase-conjugated
anti-rabbit immunoglobulin G (IgG) or anti-mouse IgG (1:10,000;
Sigma-Aldrich) secondary antibodies, as appropriate. Signals were
detected using an enhanced chemiluminescence (ECL) detection sys-
tem (GE Healthcare, Buckinghamshire, UK).
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Calcein-entrapped large unilamellar vesicles (LUVs) composed
of egg yolk L-α-phosphatidylethanolamine (EYPE)/egg yolk L-α-
phosphatidylglycerol (EYPG) (7:3, w/w) or egg yolk L-α-
phosphatidylcholine (EYPC)/cholesterol (CH) (10:1, w/w) were pre-
pared by vortexing dried lipids in dye buffer solution (70 mM calcein,
10 mM Tris [pH 7.4], 150 mM NaCl, and 0.1 mM EDTA). The suspen-
sionwas subjected to 10 cycles of freeze–thaw in liquid nitrogen and
extruded through polycarbonate ﬁlters (2 stacked 100-nm pore-size
ﬁlters) using a LiposoFast extruder (Avestin, Inc., Ottawa, Canada).
Untrapped calcein was removed by gel ﬁltration on a Sephadex
G-50 column. Passing through a Sephadex G-50 column usually
resulted in approximately a 10-fold dilution of lipid vesicles. The
eluted, calcein-entrapped vesicles were diluted further to achieve
the desired ﬁnal lipid concentration of 64 μM for experiments. The
leakage of calcein from LUVs was monitored by measuring ﬂuores-
cence intensity using an excitation wavelength of 490 nm and an
emission wavelength of 520 nm. All ﬂuorescence experiments
were performed in quartz cuvettes with a 1-cm path length using a
model RF-5301PC spectrophotometer (Shimadzu, Kyoto, Japan).
Vesicles dissolved in Tris buffer containing 10% Triton X-100
(10 μl) were used to establish 100% dye-release. The percentage of
dye-leakage caused by peptides was calculated as follows:
Dye  leakage %ð Þ ¼ 100 F−F0ð Þ= Ft−F0ð Þ
where F is the ﬂuorescence intensity of peptide-treated vesicles, and
F0 and Ft are ﬂuorescence intensities without the peptides and with
Triton X-100, respectively.
2.10. Membrane depolarization
The ability of coprisin to induce membrane depolarization was de-
termined using intact S. aureus cells and the membrane potential-
sensitive ﬂuorescent dye, 3,3′-dipropylthiadicarbo-cyanine iodide
(diSC3-5), following the methods of Friedrich et al. [36]. S. aureus
was grown at 37 °C with agitation to mid-log phase (OD600=0.4)
and harvested by centrifugation. The cells were washed twice with
washing buffer (20 mM glucose, 5 mM HEPES, pH 7.4) and
resuspended to an OD600 of 0.05 in a similar buffer containing 0.1 M
KCl. Thereafter, cells were incubated with 20 nM diSC3-5 until a stable
reduction of ﬂuorescence was achieved, indicating incorporation of
the dye into the bacterial membrane. Membrane depolarization was
then monitored by observing the change in the intensity of ﬂuores-
cence emission of diSC3-5 (λex=622 nm, λem=670 nm) after addi-
tion of peptides. Full dissipation of the membrane potential was
obtained by adding gramicidin D (0.2 nM ﬁnal concentration).
The membrane potential-dissipating activity of the peptides was cal-
culated as follows:
% Membrane depolarization ¼ 100 Fp−F0
 
= Fg−F0
 h i
where F0 is the stable ﬂuorescence value after addition of the diSC3-5
dye, Fp is the ﬂuorescence value 5 min after addition of the peptides,
and Fg is the ﬂuorescence signal after addition of gramicidin D.
2.11. Isothermal titration calorimetry (ITC)
ITC experiments were performed on nano ITC (TA instruments,
New Castle, DE) at 25 °C. All samples were dissolved in 10 mM sodi-
um phosphate buffer, pH 6.0 and degassed before use. The LPS at a
concentration of 50 μM was ﬁlled into the sample cell (volume
300 μl), reference cell was ﬁlled with phosphate buffer and 0.5 mM
coprisin was placed into the syringe (50 μl). Calorimetric titration
curve for 50 μM LPS was determined by titrating LPS with 2 μMcoprisin. After thermal equilibration, typical titration involved injec-
tions of coprisin into the sample cell containing LPS every 4 min
with constant stirring at 307 rpm. Data were collected and analyzed
using the NanoAnalyze data analysis 2.2.0 software supplied with
the instrument.
2.12. Circular dichroism analysis
Circular dichroism (CD) spectroscopy was used to investigate the
secondary structure adopted by coprisin in the following membrane-
mimetic environments: 50% 2,2,2-triﬂuoroethanol (TFE)/water solution,
50 mM dodecylphosphocholine (DPC) micelles, and 100 mM SDS mi-
celles. CD experiments were performed using a J810 spectropolarimeter
(Jasco, Tokyo, Japan) with a 1-mm path length cell. The CD spectra of
coprisin were recorded at 25 °C in 0.1-nm intervals from 190 to
250 nm. The peptide concentration was 50 μM for all CD experiments.
For each spectrum, the data from 10 scans were averaged
and smoothed using J810 software. The ﬁnal CD spectrumwas obtained
by subtracting base-line scans of both an aqueous solution and
membrane-mimicking conditions measured in the same cuvette used
for the sample. CD data were expressed as the mean residue ellipticity
(θ) in deg cm2dmol−1.
2.13. NMR analyses and structure calculations
In order to investigate the conformational changes of peptides in
the presence of DPC micelles or LPS micelles, 1H NMR spectra of
coprisin were recorded for different concentrations of lipids. The
spectra of coprisin showed severe spectral overlapping in DPC
micelles and LPS micelles. Therefore, for all NMR experiments, the
peptide was dissolved at 1.0 mM in 0.45 ml of 9:1 (v/v) H2O/D2O or
100% D2O, pH 4.3.
Phase-sensitive two-dimensional experiments, including double-
quantum-ﬁltered correlation spectroscopy (DQF-COSY), total correla-
tion spectroscopy (TOCSY), and nuclear Overhauser effect spectroscopy
(NOESY), were performed as described previously [30]. Mixing times of
80, 150, and 250 mswere used for NOESY experiments. Chemical shifts
are expressed relative to the 4,4-dimethyl-4-silapentane-1-sulfonate
signal at 0 ppm. Intramolecular hydrogen bonding in the peptides was
investigated by calculating temperature coefﬁcients from the TOCSY ex-
periments at 293, 298, 303, and 308 K. All NMR spectra were recorded
on a Bruker 500 MHz spectrometer or an 800 MHz spectrometer at
KBSI (Bruker, Rheinstetten, Germany). NMR spectra were processed
with NMRPipe [37] and visualized with Sparky [38].
Structure calculations of the peptides were carried out using the
standard protocol of the Cyana2.1 program in a LINUX environment
[39]. A total of 500 structures were calculated using the torsion
angle dynamics protocol. The structures were sorted according to
the ﬁnal value of the target function, and the best 20 structures
were analyzed in terms of distance and angle violations. The chemical
shifts, NMR-derived constraints, and coordinates are deposited in the
Biological Magnetic Resonance Bank (BMRB; accession number
18146). The atomic coordinates for 20 ﬁnal structures have been de-
posited with the Protein Data Bank under the ﬁle name 2ln4.
3. Results
3.1. Antimicrobial activity
We examined the antimicrobial activities of coprisin against a rep-
resentative set of Gram-negative bacterial strains, including E. coli,
S. typhimurium and P. aeruginosa, and Gram-positive species, including
B. subtilis, S. epidermidis and S. aureus. These results were compared
with the activities of melittin, which is known to have prominent anti-
bacterial activities against a range of bacterial strains. As summarized in
Table 1, coprisin exhibited broad-spectrum antibacterial activity. It
Table 1
Peptide relative selectivity index and antimicrobial activities against standard bacterial strains.
Peptides MIC (μM)
E. coli S. typhimurium P. aeruginosa S. aureus B. subtilis S. epidermidis GMa MHCb Relative selectivity indexc (MHC/GM)
Coprisin 0.50 2.0 8.0 2.0 2.0 16 5.1 200 39
Melittin 1.0 8.0 8.0 2.0 1.0 1.0 3.5 0.20 0.057
a The geometric mean (GM) of the minimum inhibitory concentration (MIC) values from all six bacterial strains is shown.
b The minimal peptide concentration that produces hemolysis. When no detectable hemolysis was observed at 100 μM, a value of 200 μM was used to calculate the relative
selectivity index.
c The ratio of the MHC (μM) to the GM of the MIC (μM) is given. Larger values indicate greater cell selectivity.
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bacteria than melittin, whereas it was about 16-times less potent
thanmelittin against the Gram-positive S. epidermidis. We also inves-
tigated antibacterial activities against MRSA, MDRST, and MDREC
(Table 2). These experiments showed that coprisin was active against
all antibiotic-resistant bacterial strains tested.
3.2. Hemolytic activity and cytotoxicity against mammalian cells
To determine the speciﬁcity of coprisin, we ﬁrst tested its ability to
lyse hRBCs. Concentration–response curves for the hemolytic activity
of the peptides showed that coprisin did not cause hemolysis when
present at concentrations up to 100 μM (Fig. 1A). In contrast, melittin
induced 100% hemolysis at concentrations as low as 1.56 μM. Next,
the cytotoxicities of coprisin against RAW264.7 and HaCaT cells
were determined by evaluating cell viability using MTT assays.
Whereas melittin showed signiﬁcant cytotoxicity at its MIC, coprisin
had no effect on RAW264.7 or HaCaT cell survival at its MIC, or at con-
centrations as high as 50 μM (Fig. 1B and C). Thus, coprisin was able
to discriminate between bacterial cells andmammalian cells, whereas
melittin was not.
3.3. Inhibition of NO production in LPS-stimulated RAW264.7 cells
LPS is a major component of the outer membrane of Gram-
negative bacteria. When mammals are infected by bacterial patho-
gens, LPS is released from bacterial pathogens, initiating sepsis and
inducing the systemic production of pro-inﬂammatory cytokines
and NO [40]. Using coprisin inhibition of NO production in macro-
phages as an indirect measure of the potential anti-inﬂammatory
activity of coprisin, we found that LPS (20 ng/ml)-induced NO pro-
duction in RAW264.7 mouse macrophage cells was inhibited in a
graded manner by 1.0–20 μM coprisin, as shown in Fig. 2A.
3.4. Inhibition of mTNF-α and mMIP-2 production in LPS-stimulated
RAW264.7 cells
To further investigate the anti-inﬂammatory activities of coprisin,
we tested its inhibitory effects on the production of the inﬂammatory
cytokines, mTNF-α and mMIP-2. Coprisin (1 and 10 μM) induced a
graded, 2- to 3-fold decrease in mTNF-α and mMIP-2 production in
LPS-stimulated RAW264.7 cells (Fig. 2B and C).Table 2
Antimicrobial activities of peptides against antibiotic-resistant bacterial strains.
Peptides MIC (μM)
Antibiotic-resistant bacterial strains
S. aureus
3089(R)
S. aureus
3090(R)
S. aureus
3108(R)
S. aureus
3114(R)
S. aureus
3126(R)
Coprisin 1.0 0.50 1.0 2.0 0.50
Melittin 2.0 2.0 1.0 1.0 2.03.5. Inhibition of iNOS mRNA expression in LPS-stimulated RAW264.7
cells
We further investigated coprisin regulation of inﬂammatory cyto-
kines, focusing on the production of miNOS, a key enzyme in the
generation of NO, and the inﬂammatory cytokines interleukin-1β
(mIL-1β), mTNF-α, mMIP-1, and mMIP-2. RT-PCR analyses showed
that exposure of RAW264.7 to 20 ng/ml LPS for 3 h induced a dramatic
increase in all cytokines tested, except mMIP-2, compared to that
observed in untreated macrophages (Fig. 3A). In order to compare
mRNA expression, the relative mRNA expression was quantiﬁed using
image J (NIH, Bethesda, MD, USA). In general, miNOSwas not expressed
in these cells in the absence of LPS stimulation. In cells stimulated with
20 ng/ml LPS, treatmentwith 25 μMcoprisinwas decreased respective-
ly 51%, 57%, and 59% the mRNA expression of miNOS, mIL-1β, mMIP-1.
In addition, the mRNA expressions of mTNF-α and mMIP-2 are
inhibited by 19% and 39%, respectively compared to that in coprisin
non-treated cells. These data, which are completely in accord with
previous reports of inhibition of NO production and cytokine produc-
tion by coprisin, suggest that this insect defensin possesses potent
anti-inﬂammatory activity.
3.6. Inhibition of TLR4 expression in LPS-stimulated RAW264.7 cells
Signal transduction by members of the TLR family of transmem-
brane proteins [41] is intimately linkedwith immune and inﬂammatory
responses [41–43]. Recognition of pathogenicmolecules by TLRs results
in the immediate recruitment of downstream signaling proteins, in-
cluding MyD88 (myeloid differentiation primary response gene 88),
TIRAP/Mal (toll-interleukin 1 receptor domain-containing adaptor
protein/MyD88 adapter-like) and TRIF (TIR domain-containing adapter
protein inducing IFN-β), and initiation of downstream signaling cas-
cades. To investigate the effects of coprisin on these signaling pathways,
we tested cytoplasmic extracts from coprisin-treated RAW264.7 cells
for TLR4 expression by Western analysis using an anti-TLR4 antibody.
The LPS-induced expression of TLR4was almost completely suppressed
by 20 μM coprisin (Fig. 3B). As shown in Fig. 3B, coprisin regulated
100 ng/ml LPS-stimulated activation of TLR4. Within the TLR family,
TLR4 in the plasma membrane is known to bind to LPS via LPS-
binding protein (LBP), inducing a signaling cascade that leads to im-
mune responses. These data thus strongly suggest that LPS binding to
TLR4 in LPS-stimulated, macrophage-derived RAW264.7 cells is modu-
lated by coprisin.S. typhimu.
8003(R)
S. typhimu.
8007(R)
S. typhimu.
8009(R)
E. coli
1229(R)
E. coli
1238(R)
8.0 4.0 4.0 0.50 2.0
8.0 8.0 8.0 2.0 4.0
Fig. 1. Concentration–response curves of coprisin (●) and melittin (○) for hemolytic
activity (A), cytotoxicity toward macrophage-derived RAW264.7 cells (B), and cyto-
toxicity toward HaCaT cells (C).
Fig. 2. Inhibition of nitrite production (A), mTNF-α expression (B), and mMIP-2
expression (C) by coprisin in LPS-stimulated RAW264.7 cells.
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p38 MAPK, a member of the MAP kinase family of signal transduc-
tion proteins [44] that also includes extracellular signal-regulated
kinases (ERKs) and c-Jun N-terminal kinases (JNKs), plays a role in
a signaling cascade that is activated by various extracellular signals,
including inﬂammatory cytokines, LPS, growth factors and stress,
and controls cellular responses to these stimuli. Its activation in thecontext of pro-inﬂammatory cytokines and environmental stress,
speciﬁcally in response to LPS stimulation, has been previously inves-
tigated by Raingeaud et al. [45]. Activation of p38 MAPK is mediated
by dual phosphorylation at Thr180 and Tyr182. In RAW264.7 cells,
100 ng/ml LPS caused an increase in the phosphorylation of p38,
demonstrated by Western blot analysis using an anti-phospho-p38
MAPK antibody. Treatment with 20 μM coprisin signiﬁcantly blocked
the increased phosphorylation on tyrosine and threonine in LPS-
stimulated RAW264.7 cells (Fig. 3B). Eventually, p38 MAPK partici-
pates in a signaling cascade controlling cellular responses to coprisin.
Fig. 3. Effect of coprisin on LPS-induced expression of inﬂammatory cytokines in
RAW264.7 cells. Total RNA was analyzed for the expression of IL-1β, TNF-α, iNOS,
MIP-1, MIP-2, and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (loading
control) mRNA by RT-PCR (A), effects of coprisin on TLR4 and phospho-p38 (B) and
NF-κB (C). TLR4, phospho-p38, and NF-κB protein levels were determined by Western
blot analysis using speciﬁc antibodies.
Fig. 4. Concentration–response curves of coprisin (●) and melittin (○) for induction of
calcein leakage from (A) EYPE/EYPG (7:3, w/w) and (B) EYPC/CH (10:1, w/w) LUVs.
Calcein leakage was measured 2 min after adding peptides. The lipid concentration used
in the leakage experiments was 64 μM. (C) Concentration-dependent dissipation of the
transmembrane potential of S. aureus cells (OD600=0.05) by coprisin and melittin.
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MAPK activation is modulated by TLR4 activation, and translocation
of transcription factors from the cytoplasm to the nucleus is induced by
activation (phosphorylation) of MAPKs [46,47]. To determine the rela-
tionship between the transcription factor NF-κB and the inﬂammatory
cellular response, we examined nuclear extracts for the presence of
NF-κB by Western blotting. As shown in Fig. 3C, NF-κB was highly
expressed in LPS-stimulated cells. LPS-induced NF-κB expression was
signiﬁcantly decreased in the presence of 20 μM coprisin, suggesting
that coprisin inhibits nuclear translocation of NF-κB and implying that
NF-κB-mediated signal transduction is modulated by an interaction be-
tween coprisin and LPS. Taken together with the results of the preced-
ing experiments, these ﬁndings suggest that coprisin modulates the
TLR4-p38MAPK-NF-κB signaling pathway in LPS-stimulated RAW cells.3.9. Peptide-induced permeabilization of lipid vesicles
We next investigated the effects of coprisin on membrane perme-
ability by monitoring the release of calcein, a ﬂuorescent marker, from
LUVs of different compositions. It is well accepted that negatively
charged vesicles (7:3 [w/w] EYPE/EYPG) mimic bacterial cell compo-
nent membranes whereas zwitterionic vesicles (10:1 [w/w] EYPE/CH)
mimic major components of the outer leaﬂet of human erythrocytes.
The concentration–response curves of peptide-induced calcein release,
and the effects of coprisin on this relationship, are presented in Fig. 4A
Fig. 5. Isothermal calorimetric titration of LPS with coprisin in 10 mM sodium phos-
phate buffer (pH 6.0) at 25 °C. Top: Raw experimental data of LPS titration by coprisin.
Bottom: Calorimetric titration curve for the binding of coprisin to LPS.
Fig. 6. CD spectra of peptides (50 μM, pH 4.1) in aqueous solution, 50% 2,2,2-
triﬂuoroethanol (TFE), 50 mM DPC micelles, and 100 mM SDS micelles.
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vesicles much more effectively than zwitterionic vesicles, implying
that coprisin is selective for bacterial cells. In contrast, melittin showed
no bacterial cell selectivity in these assays.
3.10. Concentration-dependent dissipation of S. aureus transmembrane
potential
Peptide-induced membrane permeation causes a dissipation of
the transmembrane potential that can be monitored as an increase
in ﬂuorescence arising from the release of the membrane potential-
sensitive ﬂuorescent dye, diSC3-5. Entry of diSC3-5 into the S. aureus
membrane strongly quenches the ﬂuorescence of the dye until dye
levels are stabilized within the membrane. To determine whether
the activity of coprisin might depend on the ability of the peptide to
permeate bacterial membranes, we used this method to monitor the
concentration-dependent dissipation of the membrane potential of
intact S. aureus cells. Addition of peptides resulted in an increase in
diSC3-5 ﬂuorescence, reﬂecting membrane potential depolarization.
It was found that the cytoplasmic membrane of intact S. aureus was
completely depolarized by 2 μM coprisin, an effect comparable to
that of melittin (Fig. 4C). These data strongly suggest that the bacte-
rial cytoplasmic membrane is a major target of coprisin. Taken
together with the results from dye-leakage experiments, these exper-
iments suggest that the antibacterial activity of coprisin may be due
to permeabilization of the bacterial cell membrane.
3.11. Isothermal titration calorimetry (ITC) experiment
Extensive studies have been performed to determine the binding
interactions of the designed peptides with LPS by ITC. The calorimet-
ric titration curve for LPS binding depends on the phase state of LPS. A
hydrophobic interaction between the peptide and LPS leads to endo-
thermic reactions in the gel phase of LPS while electrostatic interac-
tions yield exothermic reactions in the liquid crystalline phase [48].
Most AMPs display endothermic heat released and entropy-driven
process at 298 K, as characterized by an upward tendency of the
ITC. But at 313 K, above the phase transition temperature of LPS, the
interactions became exothermic and are enthalpically driven as seen
with the downward tendency of the ITC [49–51]. Titration curve for
coprisin showed that the heat of interaction between coprisin with
LPS is exothermic, characteristic of electrostatically driven interac-
tions at 298 K as shown in Fig. 5. The results suggested that high en-
thalpy contribution (ΔH=−7.96 kcal/mol) is associated with low
negative values of TΔS (−0.17 kcal/mol). Using a single site binding
model, the binding afﬁnity (Kd) of association between coprisin and
LPS has been determined to be 1.95 μM and a stoichiometry of 0.68
coprisin/LPS was obtained at pH 6.0. These results suggest that elec-
trostatic interactions between the negatively charged LPS and posi-
tively charged residues of coprisin are important.
3.12. CD measurements
To determine what secondary structure coprisin adopts in a
membrane-like environment, we examined the CD spectra of the
peptide dissolved under various membrane-mimicking conditions.
The peptide showed ordered structures in both an aqueous solution
and membrane-mimicking environments as shown in Fig. 6. Similar
to α-helical proteins, proteins in the α+β (separated α-helix and
β-sheet-rich regions) class have CD spectra that show two negative
bands around 208 and 222 nm and a positive band in the
190–195 nm region dominated by the α-helical portion. In all cases,
the 208 nm band is of larger magnitude and more prominent than
the 222 nm band for the α+β class of proteins [52]. Coprisin
exhibited characteristic strong negative maxima at 208 nm and a
shallower minimum at 220 nm, suggesting that α-helix and β-sheetstructures are separated in coprisin. This CD spectrum is similar to
that of defensin A [53]. Coprisin had similar contents of secondary
structural elements in membrane-mimicking environments as well
Table 3
Structural statistics and mean pairwise root mean squared deviations (RMSD) for the
20 lowest-energy structures of coprisin in H2O at 298 K.
Distance constraints
Short-range (|i− j|≤ |1) 288
Medium-range (1‹|i− j|≤5) 77
Long-range (5‹|i− j|) 58
Total 423
H-bond 40
Angular constraints (Φ) 30
Mean CYANA target function (Å2) 0.01±0.01
RMSD (Å)
1–43 19–42 Helix region
(19–28)
β-sheet region
(31–35, 38–42)
Backbone atoms 2.58±0.89 0.30±0.07 0.10±0.05 0.21±0.05
Heavy atoms 3.17±0.84 0.91±0.10 0.76±0.16 0.83±0.16
Ramachandran plot for the mean structure
Residues in the most favorable and additionally allowed regions (%) 99.60
Residues in generously allowed regions (%) 0.40
Residues in disallowed regions (%) 0
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structure in water because it is larger than many other AMP and has
disulﬁdes which stabilize the structure. Therefore, we determined
the tertiary structure of coprisin in an aqueous solution using NMR
spectroscopy similar to the studies of structures of other insect
defensins [54–58].
3.13. Resonance assignments
We carried out sequence-speciﬁc resonance assignments based
mainly on DQF-COSY, TOCSY, and NOESY data [59] to determine
chemical shifts of coprisin in water at 298 K, using 4,4-dimethyl-4-
silapentane-1-sulfonate as a reference. Because the spectra of coprisin
became too broad to be assigned in the presence of DPC or LPS, all
structure-determination experiments were performed in aqueous so-
lutions at pH 4.3. Sequential NOE connectivities and other NMR data
showed that coprisin had dαN(i,i+3) and dαN(i,i+4) connectivities
from Ala19 to Lys29, which are NOE connectivities characteristic of
an α-helix. The 1H chemical shift deviation, determined using the
method of Wishart et al. [60], showed a dense grouping of four or
more +1 CSI values not interrupted by a −1 value indicated the
presence of β-sheets. There were strong dαN(i,i+1) NOEs in the seg-
ments from Gly31 to Gln35 and Val38 to Arg42, and a positive 1Hα CSI,
implying that coprisin has two β-sheet structures. Amide protons in
the α-helix from Cys24 to Arg28 and those in the second β-sheet
containing Val38 and Val40 remained for 24 h after the peptide was
exchanged with D2O, suggesting that these residues contribute greatly
to the stability of the structure of coprisin.
3.14. Structure of coprisin
To determine the tertiary structure of coprisin, we took advantage of
the followingexperimental constraints: sequential (|i− j|=1),medium-
range (1b |i− j|≤5), long-range (|i− j|>5), and intraresidual distance;
hydrogen bonding constraints; and torsion angle constraints. Superim-
position of the 20 lowest-energy structures of coprisin in aqueous solu-
tion over the backbone atoms revealed that the root mean squared
deviations (RMSD) from the mean structures for residues Ala19 to
Arg42 were 0.30±0.07 Å for the backbone atoms (N, Cα, C′, O) and
0.91±0.10 Å for all heavy atoms (Fig. 7A). In contrast, the N-terminal
loop region was more poorly deﬁned than other regions, with RMSD
values larger than 2 Å. A lack of NOEs for these regions suggests that
the N-terminal loop is highly ﬂexible. The average structure is shownFig. 7. (A) The superpositions of the 20 lowest-energy structures calculated from the NMR d
superimposed. (B) Ribbon diagram of the average structure of coprisin in aqueous solution. (
as follows: yellow, hydrophobic; cyan, hydrophilic; blue, positive; red, negative; white, neuin Fig. 7B. According to a Procheck analysis, coprisin has an α-helical
structure from Ala19 to Arg28 and β-sheets from Gly31 to Gln35 and
Val38 to Val42. All residues are in the allowed region in Ramachandran
plots, as summarized in Table 3.
According to CD spectra, coprisin has a CSαβ structural motif,
which is the characteristic folding pattern of other insect defensins
[53–55,61]. Electropositive regions composed of Arg28, Lys29, Lys30,
and Arg42 are positioned at the end of the helix, turns between the
helix and the ﬁrst strand of the sheet, and the C-terminus (Fig. 7C).
Furthermore, coprisin has an amphipathic α-helix at the same
phase to these positively charged residues. The amide proton temper-
ature coefﬁcient has been used to predict hydrogen bond donors, and
values above −4.5 ppb/K indicate that the amide proton is involved
in intramolecular hydrogen bonding [62]. Temperature coefﬁcients
of the amide protons at the end of the helix (His23, Ala26, Leu27,
Arg28) and turn I (Lys29, Lys30) region of coprisin were greater than
-3.0 ppb/K, which is very stable. Furthermore, amide protons in the
α-helix from Cys24 to Arg28 and in the second β-sheet (e.g., Val38
and Val40) remained for 24 h after the protons of the peptide had
been exchanged with D2O, implying that these regions form a stable
structure.ata for coprisin in aqueous solution. The backbone atoms of residues Ala19 to Arg42 are
C) Hydrophobic and electrostatic potential surface of coprisin. Residues are color-coded
tral.
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coprisinmay contribute to the increased stability of its tertiary structure
and facilitate its interactionwith the negatively chargedmembrane sur-
face of bacteria. Fig. 8 shows the tertiary structures of six insect defensins
determined by NMR spectroscopy, and compares their hydrophobic and
electrostatic potentials. The NMR structures of three insect defensins—
coprisin, def-AAA from Anopheles gambiae, and defensin A from Phormia
terraenovae, sapecin from S. peregrina—which have basic residues locat-
ed on one side of the molecule, are shown in Fig. 8A–D. These four
defensins have an electropositive area consisting of two or three basic
residues at turn I (between the helix and the ﬁrst strand of the sheet)
and one Arg residue at the C-terminus [54–56,61]. These insect
defensins also have an amphipathic α-helical region. These positively
charged areas of defensins are important because the hydrophilic sector
faces and strongly interacts with the negatively charged head groups of
the bacterial cell membrane, resulting in bacterial cell penetration. As
shown in this ﬁgure, coprisin has a highly positive area, which consists
of three sequential basic residues. This structural feature might be im-
portant for coprisin's broad-spectrum antibacterial activity againstFig. 8. Comparison of hydrophobic and electrostatic potentials of six insect defensins dete
(E) Drosomycin. (F) Heliomycin. Top: ribbon structure. Middle: hydrophobic and electr
color-coded as follows: yellow, hydrophobic; cyan, hydrophilic; blue, positive; red, negative;
The color background corresponds to highly conserved residues. Residues are color-coded as
cysteine residues is shown by a line.Gram-negative and Gram-positive bacteria. As noted above, def-AAA
and defensin A are active against most Gram-positive bacteria and
some E. coli Gram-negative strains [63]. However, in the case of
drosomycin from Drosophila melanogaster (Fig. 8E) and heliomycin
from Heliothis virescens (Fig. 8F), negative residues are also clearly evi-
dentwithin a globally positive region, unlike the case of the three former
defensins [57,64]. Drosomycin and heliomycin have a +1 net charge
and are active against various fungal strains, but have no antibacterial
activity against Gram-positive or Gram-negative bacteria, even at con-
centrations as high as 50 μM [65,66]. The antifungal activities of
drosomycin and heliomycin suggest that the modes of action of these
two peptides, or the receptors of the target organisms, may be different
from those of other defensins. Coprisin, def-AAA, defensin A and sapecin
exhibit anti-bacterial activities and the positively charged surface with
high net charge is closely assembled at the active site. On the other
hand, at the active site of drosomycin and heliomycin, the positively
and negatively charged residues are located close together, resulting in
low net charge and no antibacterial activities against Gram-positive or
Gram-negative bacteria.rmined by NMR spectroscopy. (A) Coprisin. (B) Def-AAA. (C) Defensin A. (D) Sapecin.
ostatic potentials of the defensin. Bottom: middle panel rotated 180°. Residues are
white, neutral. (G) Complete amino acid sequences and charges of six insect defensins.
follows: yellow, hydrophobic; cyan, hydrophilic; blue, positive; red. The connectivity of
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In this study, we demonstrated that coprisin is a potent therapeutic
agentwith antibacterial aswell as anti-inﬂammatory activities. To study
the mechanism of coprisin antibacterial and anti-inﬂammatory actions,
we investigated coprisin interactions with bacterial cell membranes,
and determined the structure of coprisin, demonstrating structure–
activity relationships that provide additional insight into coprisin's
mode of action. Coprisin has a net charge of +3 and a hydrophobicity
of−1.62, calculated according to the combined consensus scale (CCS).
Hydrophobicity is the total hydrophobicity (sum of all residue hydro-
phobicity indices), according to CCS hydrophobicity scales, divided by
the number of residues [67]. Even though coprisin has a low net charge
of +3, it showed strong antibacterial activity against both Gram-
positive and Gram-negative bacteria. Aurein 2.2 and aurein 2.3 are the
AMPs with low net charges of +1 and those are also active against
S. aureus or S. epidermidis [68]. The therapeutic potential of peptide an-
tibiotic drugs lies in their ability to effectively kill bacterial cells without
exhibiting signiﬁcant cytotoxicity toward mammalian cells; this poten-
tial is conveyed by the concept of the relative selectivity index. A high
relative selectivity index thus incorporates two preferred characteristics
of the peptide: a high MHC (low hemolysis) and a low MIC (high anti-
microbial activity). The relative selectivity index of coprisin was 39,
whereas that of melittin was 0.057 (Table 1), demonstrating the bacte-
rial cell selectivity of coprisin and the absence of such selectivity for
melittin. Furthermore, coprisin showed higher antibacterial activities
against a variety of antibiotic-resistant bacterial strains, highlighting
the potential of coprisin as a potent therapeutic agent.
Permeabilization of target membranes can result in defensin-
mediated antimicrobial activity and cytotoxicity [69,70]. Non cell-
selective peptides efﬁciently bind and permeate both negatively
charged and zwitterionic phospholipid membranes, whereas most
bacterial cell-selective AMPs more efﬁciently bind and permeate neg-
atively charged phospholipid membranes [71,72]. Fluorescent dye
leakage experiments designed to address the selectivity of coprisin
for bacterial membranes showed that coprisin, at its MIC, induced
very strong leakage of entrapped ﬂuorescent dye from negatively
charged bacterial cell membrane-mimetic EYPE/EYPG (7:3, w/w)
phospholipid vesicles, but promoted much less leakage of the dye
from neutral EYPC/CH SUVs (10:1, w/w) vesicles, which mimic mam-
malian cell membranes (Fig. 4A and B). Furthermore, membrane po-
tential dissipation experiments in intact S. aureus cells indicated
that almost 100% of the cytoplasmic membrane is depolarized at
2 μM coprisin (MIC for S. aureus), an activity comparable to that of
melittin. These results strongly suggest that the bactericidal action
of coprisin is attributable to its perturbation of the bacterial cell
membrane.
In this study, coprisin exhibited broad-spectrum antibacterial
activity against Gram-positive as well as Gram-negative bacteria, but
was especially effective against E. coli, exhibiting a potency approxi-
mately twice that of melittin. Most insect defensins are known to
show antibacterial activities against a wide range of Gram-positive bac-
teria,whereas only a few are active against Gram-negative bacteria [73].
Sapecin, from Sarcophage embryonic cells, affects the growth of Gram-
positive bacteria but is largely ineffective against Gram-negative bacte-
ria tested [24]. Furthermore, def-AAA from A. gambiae and defensin A
from P. terraenovae are especially active against E. coli D22 and E. coli
D31, whereas both defensins are generally inactive against most
Gram-negative bacteria tested [63].
As shown in our previous study, the insect peptide papiliocin, a
type of insect cecropin AMP derived from swallowtail butterﬂy,
showed strongly antibacterial activities against Gram-negative bacte-
ria. Since the main component of the Gram-negative cell wall is LPS
(endotoxin), papiliocin has been thought to inhibit LPS-mediated
TLR4 stimulation and inﬂammatory signaling pathways. Our previous
study also revealed that papiliocin suppresses LPS-induced TLR4expression and NF-κB nuclear localization, implying that papiliocin
is involved in inﬂammatory responses through effects on the TLR4/
NF-κB pathway [30]. LPS is recognized by TLR4 and its accessory pro-
tein MD-2 (myeloid differentiation factor 2), which induces the secre-
tion of various inﬂammatory mediators, including TNF-α, IL-1β and
NO; these factors, in turn, are closely associated with the pathophys-
iology of septic shock and other immune diseases [15,74]. In addition
to LPS, bacterial lipopeptides of Gram-positive bacteria are recog-
nized by a combination of TLR2 and TLR6, which also recognize com-
ponents of Gram-positive bacteria and mycobacteria, such as
peptidoglycan (PGN), lipoteichoic acid, and soluble tuberculosis fac-
tor. The anti-inﬂammatory activities of human defensins are also
under intensive investigation. HNP1, -2, and -3 (α-defensins) have
been shown to increase the production of TNF-α and IL-1, and de-
crease the production of IL-10 in monocytes [75]. This supports the
hypothesis that α-defensins stimulate inﬂammatory mediators and
are involved in local inﬂammatory responses. Human β-defensin 2
(HBD2) is induced by TLR2 and TLR4 in LPS- and PGN-stimulated in-
testinal epithelial cells and is associated with JNK pathways [15,16].
HBD2 is induced in response to activation of TLR5 by S. enteritidis ﬂa-
gellin and its production is mediated by p38 and ERK pathways [17].
HBD2 and HBD3 are induced by TNF-α/interferon-γ (IFN-γ) stimula-
tion and subsequently activate the STAT1 (signal transducer and acti-
vator of transcription 1) and NF-κB signaling pathway [18].
This studyprovides theﬁrst veriﬁcation of the anti-inﬂammatory ac-
tivity and associated mechanism of the insect defensin-like peptide,
coprisin. We found that coprisin inhibited NO production and induced
a concentration-dependent decrease in mTNF-α and mMIP-2 secretion
in LPS-stimulated mouse macrophage-derived RAW264.7 cells. Nota-
bly, the activity of coprisin was comparable to that of melittin. Coprisin
also inhibited LPS-induced production of NOand suppressed expression
of mRNAs for inﬂammatory cytokines (mIL-1β, mTNF-α, mMIP-1,
mMIP-2, and mIL-6) in LPS-stimulated RAW264.7 cells. We showed
that coprisin suppresses LPS-induced TLR4 expression, p38MAPK phos-
phorylation, and NF-κB nuclear translocation, implying that coprisin is
involved in inﬂammatory responses through its effects on the p38
MAPK pathway. In particular, these data suggest that coprisin is in-
volved in an inﬂammatory cascade in which LPS stimulates TLR4,
which, once activated, might recruit neighboring molecules and trans-
fer the signal to downstream targets.
Many insect defensins have variable N-terminal loop sizes in which
the number of residues ranges from 6 to 17 between the two cysteines.
This suggests that this region may not be essential for antibacterial
activity, but may contribute to cell speciﬁcity [27]. It has been reported
that deletions or extensions within the N-terminal loop region of
defensins are related to the kinetics of action and the level of activity
[24,57,76]. The RMSD of the N-terminal loop region for the 20
superimposed structures of coprisin is much larger compared to other
regions because of the structural ﬂexibilities of this loop (Fig. 7A). The
ﬂexibility of the N-terminal loop might be important for penetration
into the bacterial cell membrane, and thus increased antimicrobial
and anti-inﬂammatory activities. However, additional studies will be
required to conﬁrm this.
On the basis of our structure–activity relationships, we have
designed 9-mer peptide analogs of coprisin containing three basic
residues from the α-helical region and turn I. The 9-mer peptide an-
alogs of coprisin exhibited antibacterial activities against Clostridium
difﬁcile [77]. Moreover, 9-mer peptide analogs showed to exhibit an
anti-inﬂammatory effect, signiﬁcantly decreasing the level of IL-6 in
C. difﬁcile-infected mice [77]. Therefore, positively charged surface
at the active site including α-helical region and turn I of coprisin
plays a key role in anti-bacterial activities.
Recently, a variety of biophysical techniques, including isothermal
titration calorimetry, differential scanning calorimetry, confocal laser
scanning microscopy, and transferred cross-saturation experiment,
saturation transfer difference and transfer nuclear Overhauser effect
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between AMP and membrane and their interactions with LPS
[61,78–82]. In the current study, the interaction of coprisin with LPS
determined using ITC resulted in exothermic reactions. These data
imply that electropositive residues containing highly positive area
formed by Arg28, Lys29, Lys30 and Arg42 in coprisin play important
roles in interactions with the negatively charged bacterial cell mem-
brane and LPS. These interactions between coprisin and the immune
system-activating LPS might plausibly disrupt LPS structures, ac-
counting for coprisin's anti-inﬂammatory activity. These properties
make coprisin a potent peptide antibiotic suitable for treating endo-
toxin shock and sepsis caused by Gram-negative bacterial infections.
In conclusion, we have demonstrated that an amphipathic helix and
an electropositive surface in coprisin may play important roles in its ef-
fective interaction with bacterial cell membranes and, ultimately, in its
high antibacterial activity and potent anti-inﬂammatory activity. This
study will provide insight to design and optimize shorter and more po-
tent peptide antibiotics on the basis of their structure–activity relation-
ships. Because coprisin also showed antibacterial activities against
Gram-positive bacteria, future studies will investigate coprisin actions
on the TLR2 cascade, stimulated by the recognition of the Gram-
positive bacterial component, PGN.
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